Allergy Therapeutics (AGY) News Today GBX 8 -0.25 (-3.03%) As of 12:06 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock AGY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Allergy Therapeutics (LON:AGY) Sets New 12-Month High - Still a Buy?1 hour ago | marketbeat.comAllergy Therapeutics plc (AGY.L) - Yahoo FinanceJuly 11 at 12:29 AM | nz.finance.yahoo.comAllergy Therapeutics (LON:AGY) Stock Price Crosses Above Fifty Day Moving Average - Should You Sell?July 9, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Sets New 12-Month High - Should You Buy?July 8, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Hits New 12-Month High - Here's WhyJuly 2, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Crosses Below 200-Day Moving Average - Here's What HappenedJune 25, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Down 5.3% - Time to Sell?June 17, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Shares Pass Below 200-Day Moving Average - Time to Sell?April 24, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Trading 11.1% Higher - Should You Buy?April 16, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Share Price Passes Below 200 Day Moving Average - Should You Sell?April 12, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Trading Down 7% - Here's What HappenedApril 4, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Releases Quarterly Earnings ResultsApril 1, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Trading Down 8.9% - Here's WhyFebruary 18, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Trading Up 2.2% - Here's WhyFebruary 4, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Down 10.4% - Here's WhyFebruary 3, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Reaches New 1-Year High - Here's What HappenedJanuary 21, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Hits New 1-Year High - Here's What HappenedJanuary 13, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Hits New 52-Week High - Here's WhyJanuary 6, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Sets New 12-Month High - Time to Buy?December 31, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Passes Above 50-Day Moving Average - Here's What HappenedDecember 31, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Sets New 12-Month High - Here's What HappenedDecember 23, 2024 | marketbeat.comSMALL CAP IDEA: Allergy Therapeutics transformation has redefined its trajectoryDecember 23, 2024 | msn.comAllergy Therapeutics (LON:AGY) Sets New 52-Week High - Here's WhyDecember 17, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Passes Above Two Hundred Day Moving Average - Should You Sell?December 17, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Shares Down 11.6% - What's Next?December 6, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Up 6.9% - Still a Buy?December 6, 2024 | marketbeat.comThose who invested in Allergy Therapeutics (LON:AGY) a year ago are up 178%November 26, 2024 | uk.finance.yahoo.comAllergy Therapeutics Seeks Approval for Grass Allergy TreatmentNovember 26, 2024 | markets.businessinsider.comAllergy Therapeutics Unveils Incentive Plans and Share RepurchaseNovember 21, 2024 | markets.businessinsider.comAllergy Therapeutics (LON:AGY) Stock Price Passes Below 200 Day Moving Average - What's Next?November 14, 2024 | marketbeat.comAllergy Therapeutics Shows Financial Turnaround and Clinical ProgressNovember 7, 2024 | markets.businessinsider.comAllergy Therapeutics Sees Growth and Strategic AdvancesNovember 7, 2024 | markets.businessinsider.comAllergy Therapeutics (LON:AGY) Shares Down 7.2% - Here's What HappenedOctober 17, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Trading Up 17.6% - What's Next?October 16, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Down 17.5% - Here's What HappenedOctober 7, 2024 | marketbeat.comECU research emphasizes proper evaluation for children with potential antibiotic allergies Research From Edith ...September 18, 2024 | msn.comAllergy Therapeutics (LON:AGY) Trading Down 9.8%September 4, 2024 | marketbeat.comAllergy Therapeutics secures cash to see it through SeptemberAugust 27, 2024 | lse.co.ukAllergy Therapeutics (LON:AGY) Shares Down 8.9% August 27, 2024 | marketbeat.comFood Allergy Awareness Week 2024: How can new treatments target an unmet need?May 16, 2024 | msn.comBuy Rating Justified for Aquestive Therapeutics Amidst Innovative Allergy Treatment and Strong Financial ProspectsMay 10, 2024 | markets.businessinsider.comGlobal Skin Allergy Testing Market Expected to Reach $771.5 Million by 2028May 9, 2024 | tmcnet.comSkin patch improves treatment for pediatric milk allergiesMay 2, 2024 | msn.comGlobal Skin Allergy Testing Market Report 2024: Revenue Data for 2020-2022, Estimated Figures for 2023, and Forecasts for 2028 - ResearchAndMarkets.comApril 27, 2024 | businesswire.comThe most common 'inhalant' allergiesApril 18, 2024 | dailymail.co.ukAllergy Therapeutics First Half 2024 Earnings: UK£0.006 loss per share (vs UK£0.013 loss in 1H 2023)March 29, 2024 | finance.yahoo.comAIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenueMarch 28, 2024 | lse.co.ukAllergy Therapeutics plc (AGY.L)March 2, 2024 | finance.yahoo.comAllergy Therapeutics PLC AGYNovember 8, 2023 | morningstar.comMAllergy Therapeutics Extends Cash Runway to End of YearNovember 6, 2023 | marketwatch.com Get Allergy Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter. Email Address AGY Media Mentions By Week AGY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGY News Sentiment▼0.251.01▲Average Medical News Sentiment AGY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGY Articles This Week▼30▲AGY Articles Average Week Get Allergy Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APH News Today ANCR News Today VLG News Today EAH News Today STX News Today CEL News Today HLN News Today BXP News Today HIK News Today HCM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AGY) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
